Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARTA.L Regulatory News (ARTA)

  • There is currently no data for ARTA

Form 8 (OPD) Artilium Plc

15 Jun 2018 16:15

RNS Number : 6109R
Artilium PLC
15 June 2018
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

PARETEUM CORPORATION

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEREE - ARTILIUM PLC

(d) Is the discloser the offeror or the offeree?

OFFEROR - PARETEUM CORPORATION

 

(e) Date position held:

The latest practicable date prior to the disclosure

14 JUNE 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

 

PARETEUM CORPORATION (OFFEROR)

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

27,695,177

7.80

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

27,695,177

7.80

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

15 June 2018

 

Contact name:

Alexander Korff

 

Telephone number:

+1 (212) 984 1096

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEDMGMVDKRGRZM
Date   Source Headline
1st Oct 20183:50 pmRNSScheme Effective
1st Oct 20187:30 amRNSSuspension - Artilium plc
28th Sep 20184:00 pmRNSCourt sanction of Scheme of Arrangement
26th Sep 20185:30 pmRNSArtilium
25th Sep 201810:30 amRNSRule 2.9 Announcement (Pareteum Corporation)
18th Sep 20189:30 amRNSRule 2.9 Announcement (Pareteum Corporation)
14th Sep 20181:30 pmRNSResult of Shareholder Meetings
13th Sep 20184:15 pmRNSPareteum Stockholder Meeting
10th Sep 201811:30 amRNSRule 2.9 Announcement (Pareteum Corporation)
6th Sep 201811:30 amRNSForm 8 (DD) - Artilium Plc
4th Sep 20185:30 pmRNSRule 2.9 Announcement (Pareteum Corporation)
28th Aug 201811:00 amRNSRule 2.9 Announcement (Pareteum Corporation)
21st Aug 201811:30 amRNSRule 2.9 Announcement (Pareteum Corporation)
20th Aug 20182:00 pmRNSPublication of Scheme Document
16th Aug 20187:00 amRNSIssue of Equity
14th Aug 201810:57 amRNSRule 2.9 Announcement (Pareteum Corporation)
8th Aug 20189:10 amRNSRule 2.9 Announcement (Pareteum Corporation)
6th Aug 20187:00 amRNSFiling of Proxy Statement (Pareteum)
12th Jul 20187:00 amRNSFirst Filing of Proxy Statement (Pareteum)
11th Jul 20187:00 amRNSPartnership with Lycamobile
6th Jul 20185:15 pmRNSRule 2.9 Announcement (Pareteum Corporation)
6th Jul 20185:15 pmRNSForm 8 (DD) - Pareteum Corporation
6th Jul 201812:00 pmRNSForm 8.3 - Artilium Plc
2nd Jul 20187:00 amRNSForm 8.3 - Pareteum Corporation
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
27th Jun 20181:00 pmRNSForm 8.3 - Artilium Plc
15th Jun 20184:15 pmRNSForm 8 (OPD) Artilium Plc
15th Jun 20184:15 pmRNSForm 8 (OPD) Pareteum Corporation
8th Jun 20184:00 pmRNSForm 8 (OPD) - Pareteum Corporation
8th Jun 201811:01 amRNSForm 8 (OPD) - Pareteum Corporation
8th Jun 201811:00 amRNSForm 8 (OPD) Artilium Plc
7th Jun 20184:22 pmRNSForm 8.3 - Artilium plc
7th Jun 20184:06 pmRNSForm 8 (DD) - Artilium plc
7th Jun 20187:00 amRNSRecommended Share and Cash Offer
11th Apr 20182:00 pmRNSAdditional Agreement with Pareteum Corporation
27th Mar 20187:00 amRNSHalf-year Report
19th Feb 20187:00 amRNSIssue of Equity
16th Jan 20187:00 amRNSSubscription, Acquisition and Issue of Equity
21st Dec 20177:00 amRNSResignation of Director
12th Dec 20173:50 pmRNSResult of AGM
24th Nov 20177:00 amRNSPosting of Annual Report & Notice of AGM
30th Oct 20177:00 amRNSFinal Results
18th Oct 20177:00 amRNSArtilium expands into Germany
16th Oct 20172:45 pmRNSStrategic partnership and share exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.